These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 10849092)
1. Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma. Silver SA; Tavassoli FA Histopathology; 2000 Jun; 36(6):505-14. PubMed ID: 10849092 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR. Radhi JM Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061 [TBL] [Abstract][Full Text] [Related]
3. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Frolik D; Caduff R; Varga Z Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309 [TBL] [Abstract][Full Text] [Related]
4. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606 [TBL] [Abstract][Full Text] [Related]
5. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031 [TBL] [Abstract][Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma. Erdem O; Dursun A; Coşkun U; Günel N Tumori; 2005; 91(1):46-52. PubMed ID: 15850004 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Zhao J; Lang R; Guo X; Chen L; Gu F; Fan Y; Fu X; Fu L Virchows Arch; 2010 Jan; 456(1):31-7. PubMed ID: 20013346 [TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737 [TBL] [Abstract][Full Text] [Related]
11. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Leal C; Henrique R; Monteiro P; Lopes C; Bento MJ; De Sousa CP; Lopes P; Olson S; Silva MD; Page DL Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366 [TBL] [Abstract][Full Text] [Related]
12. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
13. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors. Gonidi M; Athanassiadou AM; Patsouris E; Tsipis A; Dimopoulos S; Kyriakidou V; Chelidonis G; Athanassiadou P Pathol Res Pract; 2011 Jun; 207(6):377-82. PubMed ID: 21621926 [TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM; Cher-Siangang P; Tan PH Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53. Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078 [TBL] [Abstract][Full Text] [Related]
18. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439 [TBL] [Abstract][Full Text] [Related]
19. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]